Sugi Predict

Sugi Predict / Targets / STARD10

STARD10

START domain-containing protein 10 · Q9Y365 · STARD10 on Sugi Atlas →

443 patent compounds predicted against STARD10, 298 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL1233504 SCHEMBL1233504 1.00 6/20
SCHEMBL1235186 SCHEMBL1235186 1.00 6/20
SCHEMBL1235844 SCHEMBL1235844 1.00 6/20
SCHEMBL12903627 SCHEMBL12903627 1.00 6/20
SCHEMBL13470343 SCHEMBL13470343 0.85 6/20
SCHEMBL1234435 SCHEMBL1234435 0.82 6/20
SCHEMBL13275764 SCHEMBL13275764 0.77 6/20
SCHEMBL17280988 SCHEMBL17280988 0.75 6/20
SCHEMBL1235824 SCHEMBL1235824 0.72 6/20
SCHEMBL1234441 SCHEMBL1234441 0.71 6/20
SCHEMBL13470344 SCHEMBL13470344 0.60 6/20
SCHEMBL1235093 SCHEMBL1235093 1.00 5/20
SCHEMBL1235205 SCHEMBL1235205 0.81 5/20
SCHEMBL16685617 SCHEMBL16685617 0.75 5/20
SCHEMBL1233519 SCHEMBL1233519 0.73 5/20
SCHEMBL18430477 SCHEMBL18430477 0.71 5/20
SCHEMBL11560282 SCHEMBL11560282 0.51 5/20
SCHEMBL1235180 SCHEMBL1235180 1.00 4/20
SCHEMBL1233511 SCHEMBL1233511 0.85 4/20
SCHEMBL1234613 SCHEMBL1234613 0.76 4/20

Clinical trials — most relevant to STARD10 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease PHASE3RECRUITING
Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Study of STG-001 in Subjects With Stargardt Disease PHASE2COMPLETED
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1UNKNOWN
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Mitochondrial Membrane Protein Neurodegeneration (MPAN) nanCOMPLETED
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
New Genes in the Carcinogenesis of Colorectal Cancer nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
The Role of TBC1D4 in Exercise- and Insulin-induced Glucose Metabolism in Human Skeletal Muscle nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Immune Cell Response to Stimuli nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a STARD10 binder may also engage these)

ProteinNameSimilarity
Q9JMD3 — 1.000 Q9JMD3 →
Q05B84 — 0.935 Q05B84 →
Q7TPM6 — 0.930 Q7TPM6 →
Q7Z6J6 — 0.929 Q7Z6J6 →
Q6P5H6 — 0.929 Q6P5H6 →
Q9BTV5 — 0.927 Q9BTV5 →
Q8TBP0 — 0.926 Q8TBP0 →
Q91X46 — 0.923 Q91X46 →
Q5XIS9 — 0.922 Q5XIS9 →
Q4R539 — 0.922 Q4R539 →
Q9ULP0 — 0.922 Q9ULP0 →
E9PV86 — 0.921 E9PV86 →
Q6DN14 — 0.921 Q6DN14 →
Q9NR81 — 0.921 Q9NR81 →
Q9N0A8 — 0.920 Q9N0A8 →
P85298 — 0.920 P85298 →
Q5R6F2 — 0.920 Q5R6F2 →
Q09LZ8 — 0.919 Q09LZ8 →
A6QNS3 — 0.918 A6QNS3 →
PCTP Phosphatidylcholine transfer protein 0.918 landscape →
D4ABL6 — 0.918 D4ABL6 →
Q8NHH1 — 0.918 Q8NHH1 →
Q8TEW6 — 0.917 Q8TEW6 →
P02720 — 0.917 P02720 →
PRKD2 Serine/threonine-protein kinase D2 0.917 landscape →
G3V6U9 — 0.917 G3V6U9 →
A0A0G2JTR4 — 0.916 A0A0G2JTR4 →
Q8BZ03 — 0.916 Q8BZ03 →
Q8CIW5 — 0.916 Q8CIW5 →
Q9ERA0 — 0.916 Q9ERA0 →